<?xml-stylesheet type="text/xsl" href="https://www.vetnurse.co.uk/utility/feedstylesheets/rss.xsl" media="screen"?><rss version="2.0" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:slash="http://purl.org/rss/1.0/modules/slash/" xmlns:wfw="http://wellformedweb.org/CommentAPI/"><channel><title>New treatment for otitis externa in dogs</title><link>/b/veterinary-nursing-news/posts/98231</link><description>Intervet/Schering-Plough Animal Health has launched Posatex ( 1% Orbifloxacin, 0.1%
Mometasone Furoate Monohydrate and 0.1% Posaconazole, Otic Suspension ), a new
once-a-day treatment for otitis externa in dogs. 
 Posatex combines an antibacterial</description><dc:language>en-US</dc:language><generator>Telligent Community 10</generator></channel></rss>